Literature DB >> 15205430

Heterologous expression and purification of active divercin V41, a class IIa bacteriocin encoded by a synthetic gene in Escherichia coli.

Christelle Richard1, Djamel Drider, Khalil Elmorjani, Didier Marion, Hervé Prévost.   

Abstract

Divercin V41, a class IIa bacteriocin with strong antilisterial activity, is produced by Carnobacterium divergens V41. To express a recombinant version of divercin V41, we constructed a synthetic gene that encodes the mature divercin V41 peptide and then overexpressed the gene in pET-32b by using the T7 RNA polymerase promoter in the Escherichia coli Origami (DE3)(pLysS) strain. The DvnRV41 peptide was expressed as a translational fusion protein with thioredoxin and accumulated in the cell cytoplasm in a soluble anti-Listeria active form. The fusion protein was then purified and cleaved to obtain pure, soluble, folded DvnRV41 (462 microg per 20 ml of culture). This paper describes the first design of a synthetic bacteriocin gene and the first bacteriocin expressed in the E. coli cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205430      PMCID: PMC421597          DOI: 10.1128/JB.186.13.4276-4284.2004

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  60 in total

1.  Codon usage tabulated from international DNA sequence databases: status for the year 2000.

Authors:  Y Nakamura; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Bacteriocins: safe, natural antimicrobials for food preservation.

Authors:  J Cleveland; T J Montville; I F Nes; M L Chikindas
Journal:  Int J Food Microbiol       Date:  2001-12-04       Impact factor: 5.277

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm.

Authors:  P H Bessette; F Aslund; J Beckwith; G Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Characterization and heterologous expression of the genes encoding enterocin a production, immunity, and regulation in Enterococcus faecium DPC1146.

Authors:  T O'Keeffe; C Hill; R P Ross
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

6.  Covalent structure, synthesis, and structure-function studies of mesentericin Y 105(37), a defensive peptide from gram-positive bacteria Leuconostoc mesenteroides.

Authors:  Y Fleury; M A Dayem; J J Montagne; E Chaboisseau; J P Le Caer; P Nicolas; A Delfour
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

Review 7.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

8.  Functional analysis of the pediocin operon of Pediococcus acidilactici PAC1.0: PedB is the immunity protein and PedD is the precursor processing enzyme.

Authors:  K Venema; J Kok; J D Marugg; M Y Toonen; A M Ledeboer; G Venema; M L Chikindas
Journal:  Mol Microbiol       Date:  1995-08       Impact factor: 3.501

9.  Cloning, expression, and nucleotide sequence of genes involved in production of pediocin PA-1, and bacteriocin from Pediococcus acidilactici PAC1.0.

Authors:  J D Marugg; C F Gonzalez; B S Kunka; A M Ledeboer; M J Pucci; M Y Toonen; S A Walker; L C Zoetmulder; P A Vandenbergh
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

10.  Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins.

Authors:  E J Stewart; F Aslund; J Beckwith
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

View more
  21 in total

1.  Physiological and Structural Differences Between Enterococcus faecalis JH2-2 and Mutant Strains Resistant to (P)-Divercin RV41.

Authors:  S Calvez; A Kohler; H Prévost; T Møretrø; D Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2010-12       Impact factor: 4.609

2.  Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361.

Authors:  Gaoyan Wang; David C Manns; John J Churey; Randy W Worobo
Journal:  Appl Environ Microbiol       Date:  2014-06       Impact factor: 4.792

Review 3.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

4.  Insights into structure-activity relationships in the C-terminal region of divercin V41, a class IIa bacteriocin with high-level antilisterial activity.

Authors:  Jitka Rihakova; Vanessa W Petit; Katerina Demnerova; Hervé Prévost; Sylvie Rebuffat; Djamel Drider
Journal:  Appl Environ Microbiol       Date:  2009-01-30       Impact factor: 4.792

5.  Improvement of enterocin P purification process.

Authors:  S Cuozzo; S Calvez; H Prévost; D Drider
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

6.  Effect of recombinant divercin RV41, structural variants and the activators of potassium channels on Listeria monocytogenes EGDe.

Authors:  J Rihakova; H Prevost; K Demnerova; D Drider
Journal:  Folia Microbiol (Praha)       Date:  2011-04-06       Impact factor: 2.099

7.  Antimicrobial peptide m2163 or m2386 identified from Lactobacillus casei ATCC 334 can trigger apoptosis in the human colorectal cancer cell line SW480.

Authors:  Tsung-Lin Tsai; An-Chieh Li; Yi-Chieh Chen; Yi-Shun Liao; Thy-Hou Lin
Journal:  Tumour Biol       Date:  2015-01-05

Review 8.  Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic.

Authors:  Florie Desriac; Diane Defer; Nathalie Bourgougnon; Benjamin Brillet; Patrick Le Chevalier; Yannick Fleury
Journal:  Mar Drugs       Date:  2010-04-04       Impact factor: 5.118

9.  Mining and Statistical Modeling of Natural and Variant Class IIa Bacteriocins Elucidate Activity and Selectivity Profiles across Species.

Authors:  Daniel T Tresnak; Benjamin J Hackel
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

10.  In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.

Authors:  Jitka Rihakova; Jean-Michel Cappelier; Isabelle Hue; Katerina Demnerova; Michel Fédérighi; Hervé Prévost; Djamel Drider
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.